VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

Texas MPN Workshop 2022 | Venetoclax-based combinations in patients with accelerated and blast-phase MPNs

Raajit Rampal, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, briefly comments on the use of venetoclax-based combinations in patients with accelerated and blast-phase myeloproliferative neoplasms (MPNs) and the need to further evaluate the best approach to using these combinations. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter